# Immune Reconstitution of Immunosuppressed Sepsis Patients

> **NCT02797431** · PHASE2 · TERMINATED · sponsor: **University Hospital, Limoges** · enrollment: 16 (actual)

## Conditions studied

- Severe Sepsis With Septic Shock

## Interventions

- **DRUG:** Interleukin-7
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02797431
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01-14
- **Primary completion:** 2017-03-21
- **Final completion:** 2017-11-13
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** failure of supply of test product
- **Last updated:** 2017-11-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02797431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02797431, "Immune Reconstitution of Immunosuppressed Sepsis Patients". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02797431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*